EDAP TMS SA (EDAP) - Cash Flow Conversion Efficiency
Based on the latest financial reports, EDAP TMS SA (EDAP) has a cash flow conversion efficiency ratio of -0.123x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-2.38 Million) by net assets ($19.41 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
EDAP TMS SA - Cash Flow Conversion Efficiency Trend (1997–2025)
This chart illustrates how EDAP TMS SA's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read EDAP TMS SA debt and liabilities for a breakdown of total debt and financial obligations.
EDAP TMS SA Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of EDAP TMS SA ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
BHMINESLTD FPO [BHM]
AU:BHM
|
-0.306x |
|
Showbox Corp
KQ:086980
|
0.056x |
|
Info-Tek
TWO:8183
|
0.066x |
|
Yao Sheng Electronic Co Ltd
TWO:3207
|
0.005x |
|
TON Strategy Co
NASDAQ:TONX
|
-0.015x |
|
China National Accord Medicines Corp Ltd
SHE:200028
|
-0.020x |
|
Bank Negara Indonesia Tbk
JK:BBNI
|
0.385x |
|
Rav Bariach 08 Industries Ltd
TA:BRIH
|
0.045x |
Annual Cash Flow Conversion Efficiency for EDAP TMS SA (1997–2025)
The table below shows the annual cash flow conversion efficiency of EDAP TMS SA from 1997 to 2025. For the full company profile with market capitalisation and key ratios, see EDAP TMS SA market cap and net worth.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | $19.41 Million | $-13.95 Million | -0.719x | -116.32% |
| 2024-12-31 | $40.90 Million | $-13.58 Million | -0.332x | -28.82% |
| 2023-12-31 | $56.92 Million | $-14.68 Million | -0.258x | -510.79% |
| 2022-12-31 | $71.63 Million | $-3.02 Million | -0.042x | -147.54% |
| 2021-12-31 | $50.05 Million | $4.45 Million | 0.089x | +3.42% |
| 2020-12-31 | $26.25 Million | $2.25 Million | 0.086x | -38.18% |
| 2019-12-31 | $27.36 Million | $3.80 Million | 0.139x | +1881.34% |
| 2018-12-31 | $24.96 Million | $175.00K | 0.007x | +105.77% |
| 2017-12-31 | $25.16 Million | $-3.06 Million | -0.122x | -365.69% |
| 2016-12-31 | $24.45 Million | $1.12 Million | 0.046x | -50.64% |
| 2015-12-31 | $14.43 Million | $1.34 Million | 0.093x | +238.45% |
| 2014-12-31 | $15.14 Million | $-1.01 Million | -0.067x | +75.08% |
| 2013-12-31 | $9.28 Million | $-2.50 Million | -0.269x | -1253.83% |
| 2012-12-31 | $8.16 Million | $-162.00K | -0.020x | +76.53% |
| 2011-12-31 | $8.71 Million | $-737.00K | -0.085x | +80.28% |
| 2010-12-31 | $8.90 Million | $-3.82 Million | -0.429x | -47.28% |
| 2009-12-31 | $12.58 Million | $-3.66 Million | -0.291x | -9.02% |
| 2008-12-31 | $17.19 Million | $-4.59 Million | -0.267x | -41.95% |
| 2007-12-31 | $14.52 Million | $-2.73 Million | -0.188x | -91.08% |
| 2006-12-31 | $19.30 Million | $-1.90 Million | -0.099x | -500.94% |
| 2005-12-31 | $17.36 Million | $-284.53K | -0.016x | +74.02% |
| 2004-12-31 | $17.95 Million | $-1.13 Million | -0.063x | +67.23% |
| 2003-12-31 | $18.93 Million | $-3.64 Million | -0.192x | +31.41% |
| 2002-12-31 | $28.40 Million | $-7.97 Million | -0.281x | -221.04% |
| 2001-12-31 | $38.98 Million | $-3.41 Million | -0.087x | -10295.04% |
| 2000-12-31 | $34.78 Million | $29.81K | 0.001x | +100.52% |
| 1999-12-31 | $15.47 Million | $-2.54 Million | -0.164x | +36.19% |
| 1998-12-31 | $24.90 Million | $-6.39 Million | -0.257x | -2288.70% |
| 1997-12-31 | $33.82 Million | $-363.64K | -0.011x | -- |
About EDAP TMS SA
EDAP TMS S.A., together with its subsidiaries, develops, manufactures, promotes, and distributes minimally-invasive medical devices for urology based upon proprietary ultrasound technology in Asia, France, the United States, and internationally. The company operates through High Intensity Focused Ultrasound (HIFU), Extracorporeal ShockWave Lithotripsy (ESWL), and Distribution segments. The HIFU s… Read more